Clinical data for Episealer® to be presented at sports medicine congress in the United Kingdom
Episurf Medical (Nasdaq: EPIS B) today announces that its implant technology, and clinical results from the use of the Episealer® implant, will be presented at the sports medicine congress “Sports Knee 2019”. The congress will be arranged at St George’s Park Burton-on-Trent on November 25-26, 2019. The presentation will be held by Associate Professor Tim Spalding, University Hospitals Coventry and Warwickshire NHS Trust.
The clinical results come from a European multicenter study with 100 patients in the “gap age”, 35-60 years old, that have undergone treatment of focal chondral defects using the knee implant Episealer®. The results show excellent early clinical results from the treatment of focal symptomatic cartilage lesions on the femoral condyles and the trochlea area in the knee joint.
“We highly appreciate the significant interest in our treatment alternative, and our user’s initiative to share their experiences from their use of our Episealer® knee implant is of great importance. It’s also highly motivating for us as a company to hear about the strong clinical results from the ongoing study” says Pål Ryfors, CEO Episurf Medical.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
Tags: